Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers
about
Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers
description
clinical trial
@en
klinisch onderzoek
@nl
name
Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers
@en
type
label
Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers
@en
prefLabel
Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers
@en
P1476
Phase II Study of the Combinat ...... vanced Neuroendocrine Cancers.
@en
P3098
NCT01121939
P580
2010-05-01T00:00:00Z
P582
2015-02-01T00:00:00Z